SGLT2 inhibitors not linked to increased bladder cancer risk: Study Jacinthlyn Sylvia19 Oct 2022 8:15 PM ISTA recent study by Devin Abrahami published in the journal of Diabetes Care found that sodium-glucose cotransporter 2 (SGLT2) inhibitors are not...
SGLT2 inhibitors and GLP1 receptor antagonists effectively control blood sugar but are prohibitively expensive Dr. Kamal Kant Kohli13 Oct 2022 7:30 PM ISTSGLT2 and GLP1 have been found to reduce atherosclerotic cardiovascular disease (ASCVD), microvascular disease, and mortality in addition to improving...
SGLT2 inhibitors reduce HF, MACE and improve kidney outcomes in CKD: ADA/ EASD consensus report Medha Baranwal30 Sept 2022 12:00 PM ISTSGLT2 inhibitors should be used in patients with heart failure (HF) because they improve kidney and HF outcomes, according to a consensus report...
Is supplementation of SGLT-2 inhibitor beneficial for obese women with PCOS? Medha Baranwal28 Sept 2022 9:30 PM ISTChina: Canagliflozin and metformin combination therapy yields similar results as metformin monotherapy for improving weight control,...
Use of SGLT2 inhibitors reduces risk of dry eye disease: JAMA Dr. Kamal Kant Kohli27 Sept 2022 7:30 PM ISTTAIWAN: According to the researchers of a large retrospective study reported in JAMA Network Open, one advantage of SGLT2 inhibitors in people with...
SGLT2 inhibitors optimal for treating HF with preserved and mildly reduced ejection fraction: JAMA Medha Baranwal26 Sept 2022 10:00 AM ISTChina: A recent study has suggested that SGLT2 inhibitors are the optimal drug class for heart failure with preserved ejection fraction (HFpEF) and...
SGLT2 inhibitors may lower BMI and waist circumference in obese nondiabetics: Study Medha Baranwal20 Sept 2022 8:00 PM ISTIran: The sodium-glucose co-transporter-2 (SGLT2) inhibitors improve some metabolic and anthropometric markers in individuals without diabetes who are...
Rare case of Fungal Ball in Urinary Bladder reported in NEJM Dr. Kamal Kant Kohli12 Sept 2022 9:00 AM ISTDr Chieh-Ying Chang and Ming-Han Hsieh have reported a rare case of fungal ball in Urinary Bladder that has been published in New England journal of...
SGLT2 inhibitors useful for HF patients with mildly reduced and preserved ejection fraction: Deliver Trial Dr. Kamal Kant Kohli7 Sept 2022 11:00 AM ISTPrevious studies have shown that the SGLT2 inhibitor dapagliflozin reduces cardiovascular mortality and morbidity in patients with diabetes, chronic...
SGLT2 inhibitors may reduce resting BP and skeletal muscle reflexes independent of glycemic control Medha Baranwal31 Aug 2022 12:00 PM ISTDallas, TX: Recent data have shown a novel role for SGLT2 inhibitors independent of glycemic control, in reducing resting blood pressure (BP) and...
Increasing empagliflozin dose provides significant clinical benefits in type 2 diabetes: Study Medha Baranwal18 Aug 2022 7:30 PM ISTJapan: Switching from low-dose to high-dose SGLT2 inhibitor empagliflozin provides significant clinical benefits in patients with type 2 diabetes...
DPP4i and GLP1Ra as effective as insulin for in-hospital management of diabetes: Study Medha Baranwal12 Aug 2022 12:45 PM ISTColombia: Inpatient management of type 2 diabetes patients in the general ward with GLP1Ra and DPP4i is equally safe and effective compared to insulin...
